Works by Habermann, Thomas M.
Results: 166
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
- By:
- Publication type:
- Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00711-8
- By:
- Publication type:
- Article
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00521-4
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00394-z
- By:
- Publication type:
- Article
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 5, p. 784, doi. 10.1002/ijc.11311
- By:
- Publication type:
- Article
Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Stage IE Primary Gastric Lymphoma.
- Published in:
- Acta Haematologica, 1995, v. 94, n. 2, p. 59, doi. 10.1159/000203975
- By:
- Publication type:
- Article
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
- By:
- Publication type:
- Article
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
- Published in:
- British Journal of Haematology, 1992, v. 80, n. 4, p. 466, doi. 10.1111/j.1365-2141.1992.tb04559.x
- By:
- Publication type:
- Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-Term Follow-Up of Patients with Monoclonal Gammopathy of Undetermined Significance after Kidney Transplantation.
- Published in:
- American Journal of Nephrology, 2012, v. 35, n. 4, p. 365, doi. 10.1159/000337482
- By:
- Publication type:
- Article
New developments in the management of diffuse large B-cell lymphoma.
- Published in:
- Hematology, 2012, v. 17, p. 93, doi. 10.1179/102453312X13336169156014
- By:
- Publication type:
- Article
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study.
- Published in:
- Thyroid, 2016, v. 26, n. 8, p. 1061, doi. 10.1089/thy.2016.0095
- By:
- Publication type:
- Article
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
- Published in:
- Nutrition & Cancer, 2018, v. 70, n. 7, p. 1088, doi. 10.1080/01635581.2018.1502328
- By:
- Publication type:
- Article
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 12, p. 2993, doi. 10.1002/cncr.25114
- By:
- Publication type:
- Article
The Treatment of Recurrent/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Everolimus Results in Clinical Responses and Mobilization of CLL Cells Into the Circulation.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2201, doi. 10.1002/cncr.25005
- By:
- Publication type:
- Article
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2826, doi. 10.1002/cncr.22342
- By:
- Publication type:
- Article
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 524, doi. 10.1111/bjh.15720
- By:
- Publication type:
- Article
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 149, doi. 10.1111/bjh.14922
- By:
- Publication type:
- Article
Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 5, p. 644, doi. 10.1111/bjh.15416
- By:
- Publication type:
- Article
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near <italic>MYC</italic>/<italic>PVT1</italic> predicts patient outcome in two independent cohorts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 50, doi. 10.1111/bjh.14813
- By:
- Publication type:
- Article
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 3, p. 427, doi. 10.1111/bjh.14688
- By:
- Publication type:
- Article
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 867, doi. 10.1111/bjh.14007
- By:
- Publication type:
- Article
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 530, doi. 10.1111/bjh.13634
- By:
- Publication type:
- Article
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 56, doi. 10.1111/bjh.13389
- By:
- Publication type:
- Article
A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 3, p. 358, doi. 10.1111/bjh.12753
- By:
- Publication type:
- Article
Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 39, doi. 10.1111/bjh.12717
- By:
- Publication type:
- Article
Diffuse large B-cell lymphoma ( Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 6, p. 774, doi. 10.1111/bjh.12458
- By:
- Publication type:
- Article
Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 639, doi. 10.1111/bjh.12449
- By:
- Publication type:
- Article
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 3, p. 321, doi. 10.1111/j.1365-2141.2012.09067.x
- By:
- Publication type:
- Article
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 2, p. 143, doi. 10.1111/j.1365-2141.2010.08331.x
- By:
- Publication type:
- Article
Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 5, p. 614, doi. 10.1111/j.1365-2141.2009.07675.x
- By:
- Publication type:
- Article
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 344, doi. 10.1111/j.1365-2141.2009.07626.x
- By:
- Publication type:
- Article
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 3, p. 398, doi. 10.1111/j.1365-2141.2007.06801.x
- By:
- Publication type:
- Article
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 5, p. 409, doi. 10.1111/j.1365-2141.2007.06596.x
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article